GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » Asset Turnover

Encision (Encision) Asset Turnover : 0.35 (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Encision Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Encision's Revenue for the three months ended in Dec. 2023 was $1.58 Mil. Encision's Total Assets for the quarter that ended in Dec. 2023 was $4.49 Mil. Therefore, Encision's Asset Turnover for the quarter that ended in Dec. 2023 was 0.35.

Asset Turnover is linked to ROE % through Du Pont Formula. Encision's annualized ROE % for the quarter that ended in Dec. 2023 was -36.27%. It is also linked to ROA % through Du Pont Formula. Encision's annualized ROA % for the quarter that ended in Dec. 2023 was -18.45%.


Encision Asset Turnover Historical Data

The historical data trend for Encision's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encision Asset Turnover Chart

Encision Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.64 1.88 1.45 1.47 1.65

Encision Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.44 0.41 0.42 0.35

Competitive Comparison of Encision's Asset Turnover

For the Medical Instruments & Supplies subindustry, Encision's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encision's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Encision's Asset Turnover falls into.



Encision Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Encision's Asset Turnover for the fiscal year that ended in Mar. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=7.349/( (4.792+4.134)/ 2 )
=7.349/4.463
=1.65

Encision's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1.582/( (4.689+4.287)/ 2 )
=1.582/4.488
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Encision  (OTCPK:ECIA) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Encision's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-0.828/2.283
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.828 / 6.328)*(6.328 / 4.488)*(4.488/ 2.283)
=Net Margin %*Asset Turnover*Equity Multiplier
=-13.08 %*1.41*1.9658
=ROA %*Equity Multiplier
=-18.45 %*1.9658
=-36.27 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Encision's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-0.828/4.488
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.828 / 6.328)*(6.328 / 4.488)
=Net Margin %*Asset Turnover
=-13.08 %*1.41
=-18.45 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Encision Asset Turnover Related Terms

Thank you for viewing the detailed overview of Encision's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Encision (Encision) Business Description

Traded in Other Exchanges
N/A
Address
6797 Winchester Circle, Boulder, CO, USA, 80301
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.
Executives
Robert H Fries director 800 FILLMORE ST, DENVER CO 80206
Peter D Geary officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson officer: VP Sales 17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Gregory J. Trudel director, officer: CEO 5241 RIMROCK LANE, FORT COLLINS CO 80526
Brian J Jackman director 6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul director 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker director 6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen director, 10 percent owner 4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed 10 percent owner
Patrick W Pace director 3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs officer: VP Engineering 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse officer: VP RA/QA 6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray officer: VP of Operations 6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton director, officer: VP Technology 8099 NORTH 63RD STREET, LONGMONT CO 80503

Encision (Encision) Headlines

From GuruFocus

Encision Reports First Quarter Fiscal Year 2022 Results

By PRNewswire PRNewswire 08-09-2021

Encision Reports First Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 08-12-2019

Encision Reports Third Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 02-06-2020

Encision Introduces Its AEM® 2X enTouch® Scissors

By PRNewswire PRNewswire 08-05-2020

Encision Reports Third Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 02-07-2019

Encision Reports Fourth Quarter Fiscal Year 2020 Results

By PRNewswire PRNewswire 05-14-2020

Encision Completes Private Placement of Common Stock

By PRNewswire PRNewswire 12-20-2018

Encision Signs Supplier Agreement with Human Xtensions

By ACCESSWIRE ACCESSWIRE 02-28-2023

Encision Reports First Quarter Fiscal Year 2019 Results

By PRNewswire PRNewswire 08-02-2018